Showing results (181-190 of 250) with videos related to
Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|September 1, 2018
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone TherapyAlejandro Berlin, Jure Murgic, Ali Hosni, et al.Nature Methods|September 1, 2014
SeqControl: process control for DNA sequencingLauren C Chong, Marco A Albuquerque, Nicholas J Harding, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local InflammationJorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar, et al.International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trialsWendy A Woodward, Robert G Bristow, Michael F Clarke, et al.Cancer Research|September 17, 2010
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancerAnanya Choudhury, Louisa D Nelson, Mark T W Teo, et al.International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meetingCatharine M L West, Michael J McKay, Tobias Hölscher, et al.Oncogene|February 16, 2016
Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathwayL Fabris, S Berton, F Citron, et al.Molecular Oncology|January 23, 2016
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapiesA Rajan, A Berns, U Ringborg, et al.Molecular and Cellular Biology|August 23, 2002
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent mannerAtsushi Hirao, Alison Cheung, Gordon Duncan, et al.BMJ Open|April 25, 2020
[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.Pageof 25